Industry Research Reports
Global Octreotide Market Insights, Forecast to 2030
Industry: Pharma & Healthcare
Published Date: 2024-04-07
Pages: 96 Pages
Report ld: 2713637
Request Sample
Customized Report
- Description
- Table of Contents
- Table of Figures
- Related Reports
PDF Download
- Description
- Table of Contents
- Table of Figures
- Related Reports
- PDF Download
Octreotide Market Size(US$)
CAGR 2024-2030
-2.8%
Market Size,2030
USD 2
Million
Market Snapshot
Market Size in 2024 (Value)
US$ 3 million
Market Forecast in 2030(Value)
US$ 2 million
CAGR
-2.8%
Years Considered
2019-2030
Base Year
2024
Forecast Period
2024-2030
Source: Secondary research, interviews with experts, and QYResearch analysis
Octreotide is an octapeptide that mimics natural somatostatin pharmacologically，it is a more potent inhibitor of growth hormone, glucagon, and insulin than the natural hormone. Usually in the form of a salt of acetic acid.
The global Octreotide market is projected to grow from US$ 3 million in 2024 to US$ 2 million by 2030, at a Compound Annual Growth Rate (CAGR) of -2.8% during the forecast period.
Global Octreotide key players include Novartis, SUN, Tiantaishan pharmaceutical, Sinopharm A-Think, Sihuan Pharmaceutical, etc. Global top five manufacturers hold a share over 90%.
Europe is the largest market, with a share over 65%, followed by India and China, both have a share over 30%.
Report Covers:
This report presents an overview of global market for Octreotide, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Octreotide, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Octreotide, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Octreotide sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Octreotide market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type, and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Octreotide sales, projected growth trends, production technology, application and end-user industry.
MARKET SEGMENTATION
By Company
- Novartis
- Sun Pharmaceutical
- Chengdu Tiantaishan pharmaceutical
- Sinopharm A-Think Pharmaceuticals
- Sihuan Pharmaceutical Holdings Group
- Shanghai Soho-Yiming Pharmaceuticals
- Yibin Pharmaceutical
Consumption by Region
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
- Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Segment by Type
- Octreotide Injection
- Octreotide Powder
- Octreotide Microspheres
Segment by Application
- Treating Severe Diarrhea
- Treating Acromegaly
- Others
CHAPTER OUTLINE
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Octreotide in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 3: Detailed analysis of Octreotide manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, sales, and revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, sales, and revenue for each segment.
Chapter 8: China by Type, and by Application, sales, and revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, sales, and revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Octreotide sales, revenue, price, gross margin, and recent development, etc.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: The main points and conclusions of the report.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
Market entry risks/opportunities by region
We identify regional market threats and growth prospects to guide your overseas layout.
Product mix optimization based on local practices
We adjust product portfolios in line with local consumption habits.
Competitor tactics in fragmented vs. consolidated markets
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
Full Research Coverage
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
19 Years Industry Expertise
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
24/7 Fast Report Delivery
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
Localized Strategic Analysis
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
Market entry risks/opportunities by region
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
Market entry risks/opportunities by region
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Study Coverage
1.1 Octreotide Product Introduction
1.2 Market by Type
1.2.1 Global Octreotide Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 Octreotide Injection
1.2.3 Octreotide Powder
1.2.4 Octreotide Microspheres
1.3 Market by Application
1.3.1 Global Octreotide Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Treating Severe Diarrhea
1.3.3 Treating Acromegaly
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Octreotide Sales Estimates and Forecasts 2019-2030
2.2 Global Octreotide Revenue by Region
2.2.1 Global Octreotide Revenue by Region: 2019 VS 2023 VS 2030
2.2.2 Global Octreotide Revenue by Region (2019-2024)
2.2.3 Global Octreotide Revenue by Region (2025-2030)
2.2.4 Global Octreotide Revenue Market Share by Region (2019-2030)
2.3 Global Octreotide Sales Estimates and Forecasts 2019-2030
2.4 Global Octreotide Sales by Region
2.4.1 Global Octreotide Sales by Region: 2019 VS 2023 VS 2030
2.4.2 Global Octreotide Sales by Region (2019-2024)
2.4.3 Global Octreotide Sales by Region (2025-2030)
2.4.4 Global Octreotide Sales Market Share by Region (2019-2030)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Octreotide Sales by Manufacturers
3.1.1 Global Octreotide Sales by Manufacturers (2019-2024)
3.1.2 Global Octreotide Sales Market Share by Manufacturers (2019-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Octreotide in 2023
3.2 Global Octreotide Revenue by Manufacturers
3.2.1 Global Octreotide Revenue by Manufacturers (2019-2024)
3.2.2 Global Octreotide Revenue Market Share by Manufacturers (2019-2024)
3.2.3 Global Top 10 and Top 5 Companies by Octreotide Revenue in 2023
3.3 Global Key Players of Octreotide, Industry Ranking, 2022 VS 2023 VS 2024
3.4 Global Octreotide Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Octreotide Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Octreotide, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Octreotide, Product Offered and Application
3.8 Global Key Manufacturers of Octreotide, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Octreotide Sales by Type
4.1.1 Global Octreotide Historical Sales by Type (2019-2024)
4.1.2 Global Octreotide Forecasted Sales by Type (2025-2030)
4.1.3 Global Octreotide Sales Market Share by Type (2019-2030)
4.2 Global Octreotide Revenue by Type
4.2.1 Global Octreotide Historical Revenue by Type (2019-2024)
4.2.2 Global Octreotide Forecasted Revenue by Type (2025-2030)
4.2.3 Global Octreotide Revenue Market Share by Type (2019-2030)
4.3 Global Octreotide Price by Type
4.3.1 Global Octreotide Price by Type (2019-2024)
4.3.2 Global Octreotide Price Forecast by Type (2025-2030)
5 Market Size by Application
5.1 Global Octreotide Sales by Application
5.1.1 Global Octreotide Historical Sales by Application (2019-2024)
5.1.2 Global Octreotide Forecasted Sales by Application (2025-2030)
5.1.3 Global Octreotide Sales Market Share by Application (2019-2030)
5.2 Global Octreotide Revenue by Application
5.2.1 Global Octreotide Historical Revenue by Application (2019-2024)
5.2.2 Global Octreotide Forecasted Revenue by Application (2025-2030)
5.2.3 Global Octreotide Revenue Market Share by Application (2019-2030)
5.3 Global Octreotide Price by Application
5.3.1 Global Octreotide Price by Application (2019-2024)
5.3.2 Global Octreotide Price Forecast by Application (2025-2030)
6 US & Canada
6.1 US & Canada Octreotide Market Size by Type
6.1.1 US & Canada Octreotide Sales by Type (2019-2030)
6.1.2 US & Canada Octreotide Revenue by Type (2019-2030)
6.2 US & Canada Octreotide Market Size by Application
6.2.1 US & Canada Octreotide Sales by Application (2019-2030)
6.2.2 US & Canada Octreotide Revenue by Application (2019-2030)
6.3 US & Canada Octreotide Market Size by Country
6.3.1 US & Canada Octreotide Revenue by Country: 2019 VS 2023 VS 2030
6.3.2 US & Canada Octreotide Sales by Country (2019-2030)
6.3.3 US & Canada Octreotide Revenue by Country (2019-2030)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Octreotide Market Size by Type
7.1.1 Europe Octreotide Sales by Type (2019-2030)
7.1.2 Europe Octreotide Revenue by Type (2019-2030)
7.2 Europe Octreotide Market Size by Application
7.2.1 Europe Octreotide Sales by Application (2019-2030)
7.2.2 Europe Octreotide Revenue by Application (2019-2030)
7.3 Europe Octreotide Market Size by Country
7.3.1 Europe Octreotide Revenue by Country: 2019 VS 2023 VS 2030
7.3.2 Europe Octreotide Sales by Country (2019-2030)
7.3.3 Europe Octreotide Revenue by Country (2019-2030)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Octreotide Market Size
8.1.1 China Octreotide Sales (2019-2030)
8.1.2 China Octreotide Revenue (2019-2030)
8.2 China Octreotide Market Size by Application
8.2.1 China Octreotide Sales by Application (2019-2030)
8.2.2 China Octreotide Revenue by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia Octreotide Market Size by Type
9.1.1 Asia Octreotide Sales by Type (2019-2030)
9.1.2 Asia Octreotide Revenue by Type (2019-2030)
9.2 Asia Octreotide Market Size by Application
9.2.1 Asia Octreotide Sales by Application (2019-2030)
9.2.2 Asia Octreotide Revenue by Application (2019-2030)
9.3 Asia Octreotide Sales by Region
9.3.1 Asia Octreotide Revenue by Region: 2019 VS 2023 VS 2030
9.3.2 Asia Octreotide Revenue by Region (2019-2030)
9.3.3 Asia Octreotide Sales by Region (2019-2030)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Octreotide Market Size by Type
10.1.1 Middle East, Africa and Latin America Octreotide Sales by Type (2019-2030)
10.1.2 Middle East, Africa and Latin America Octreotide Revenue by Type (2019-2030)
10.2 Middle East, Africa and Latin America Octreotide Market Size by Application
10.2.1 Middle East, Africa and Latin America Octreotide Sales by Application (2019-2030)
10.2.2 Middle East, Africa and Latin America Octreotide Revenue by Application (2019-2030)
10.3 Middle East, Africa and Latin America Octreotide Sales by Country
10.3.1 Middle East, Africa and Latin America Octreotide Revenue by Country: 2019 VS 2023 VS 2030
10.3.2 Middle East, Africa and Latin America Octreotide Revenue by Country (2019-2030)
10.3.3 Middle East, Africa and Latin America Octreotide Sales by Country (2019-2030)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 Novartis
11.1.1 Novartis Company Information
11.1.2 Novartis Overview
11.1.3 Novartis Octreotide Sales, Price, Revenue and Gross Margin (2019-2024)
11.1.4 Novartis Octreotide Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Novartis Recent Developments
11.2 Sun Pharmaceutical
11.2.1 Sun Pharmaceutical Company Information
11.2.2 Sun Pharmaceutical Overview
11.2.3 Sun Pharmaceutical Octreotide Sales, Price, Revenue and Gross Margin (2019-2024)
11.2.4 Sun Pharmaceutical Octreotide Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Sun Pharmaceutical Recent Developments
11.3 Chengdu Tiantaishan pharmaceutical
11.3.1 Chengdu Tiantaishan pharmaceutical Company Information
11.3.2 Chengdu Tiantaishan pharmaceutical Overview
11.3.3 Chengdu Tiantaishan pharmaceutical Octreotide Sales, Price, Revenue and Gross Margin (2019-2024)
11.3.4 Chengdu Tiantaishan pharmaceutical Octreotide Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Chengdu Tiantaishan pharmaceutical Recent Developments
11.4 Sinopharm A-Think Pharmaceuticals
11.4.1 Sinopharm A-Think Pharmaceuticals Company Information
11.4.2 Sinopharm A-Think Pharmaceuticals Overview
11.4.3 Sinopharm A-Think Pharmaceuticals Octreotide Sales, Price, Revenue and Gross Margin (2019-2024)
11.4.4 Sinopharm A-Think Pharmaceuticals Octreotide Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Sinopharm A-Think Pharmaceuticals Recent Developments
11.5 Sihuan Pharmaceutical Holdings Group
11.5.1 Sihuan Pharmaceutical Holdings Group Company Information
11.5.2 Sihuan Pharmaceutical Holdings Group Overview
11.5.3 Sihuan Pharmaceutical Holdings Group Octreotide Sales, Price, Revenue and Gross Margin (2019-2024)
11.5.4 Sihuan Pharmaceutical Holdings Group Octreotide Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Sihuan Pharmaceutical Holdings Group Recent Developments
11.6 Shanghai Soho-Yiming Pharmaceuticals
11.6.1 Shanghai Soho-Yiming Pharmaceuticals Company Information
11.6.2 Shanghai Soho-Yiming Pharmaceuticals Overview
11.6.3 Shanghai Soho-Yiming Pharmaceuticals Octreotide Sales, Price, Revenue and Gross Margin (2019-2024)
11.6.4 Shanghai Soho-Yiming Pharmaceuticals Octreotide Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Shanghai Soho-Yiming Pharmaceuticals Recent Developments
11.7 Yibin Pharmaceutical
11.7.1 Yibin Pharmaceutical Company Information
11.7.2 Yibin Pharmaceutical Overview
11.7.3 Yibin Pharmaceutical Octreotide Sales, Price, Revenue and Gross Margin (2019-2024)
11.7.4 Yibin Pharmaceutical Octreotide Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Yibin Pharmaceutical Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Octreotide Industry Chain Analysis
12.2 Octreotide Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Octreotide Production Mode & Process
12.4 Octreotide Sales and Marketing
12.4.1 Octreotide Sales Channels
12.4.2 Octreotide Distributors
12.5 Octreotide Customers
13 Market Dynamics
13.1 Octreotide Industry Trends
13.2 Octreotide Market Drivers
13.3 Octreotide Market Challenges
13.4 Octreotide Market Restraints
14 Key Findings in The Global Octreotide Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
TABLE OF FIGURES
List of Tables
Table 1. Global Octreotide Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
Table 2. Major Manufacturers of Octreotide Injection
Table 3. Major Manufacturers of Octreotide Powder
Table 4. Major Manufacturers of Octreotide Microspheres
Table 5. Global Octreotide Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
Table 6. Global Octreotide Revenue Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 7. Global Octreotide Revenue by Region (2019-2024) & (US$ Million)
Table 8. Global Octreotide Revenue by Region (2025-2030) & (US$ Million)
Table 9. Global Octreotide Revenue Market Share by Region (2019-2024)
Table 10. Global Octreotide Revenue Market Share by Region (2025-2030)
Table 11. Global Octreotide Sales Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 12. Global Octreotide Sales by Region (2019-2024) & (Gram)
Table 13. Global Octreotide Sales by Region (2025-2030) & (Gram)
Table 14. Global Octreotide Sales Market Share by Region (2019-2024)
Table 15. Global Octreotide Sales Market Share by Region (2025-2030)
Table 16. Global Octreotide Sales by Manufacturers (2019-2024) & (Gram)
Table 17. Global Octreotide Sales Share by Manufacturers (2019-2024)
Table 18. Global Octreotide Revenue by Manufacturers (2019-2024) & (US$ Million)
Table 19. Global Octreotide Revenue Share by Manufacturers (2019-2024)
Table 20. Global Key Players of Octreotide, Industry Ranking, 2022 VS 2023 VS 2024
Table 21. Octreotide Price by Manufacturers 2019-2024 (USD/Gram)
Table 22. Global Octreotide Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 23. Global Octreotide by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Octreotide as of 2023)
Table 24. Global Key Manufacturers of Octreotide, Manufacturing Base Distribution and Headquarters
Table 25. Global Key Manufacturers of Octreotide, Product Offered and Application
Table 26. Global Key Manufacturers of Octreotide, Date of Enter into This Industry
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Octreotide Sales by Type (2019-2024) & (Gram)
Table 29. Global Octreotide Sales by Type (2025-2030) & (Gram)
Table 30. Global Octreotide Sales Share by Type (2019-2024)
Table 31. Global Octreotide Sales Share by Type (2025-2030)
Table 32. Global Octreotide Revenue by Type (2019-2024) & (US$ Million)
Table 33. Global Octreotide Revenue by Type (2025-2030) & (US$ Million)
Table 34. Global Octreotide Revenue Share by Type (2019-2024)
Table 35. Global Octreotide Revenue Share by Type (2025-2030)
Table 36. Octreotide Price by Type (2019-2024) & (USD/Gram)
Table 37. Global Octreotide Price Forecast by Type (2025-2030) & (USD/Gram)
Table 38. Global Octreotide Sales by Application (2019-2024) & (Gram)
Table 39. Global Octreotide Sales by Application (2025-2030) & (Gram)
Table 40. Global Octreotide Sales Share by Application (2019-2024)
Table 41. Global Octreotide Sales Share by Application (2025-2030)
Table 42. Global Octreotide Revenue by Application (2019-2024) & (US$ Million)
Table 43. Global Octreotide Revenue by Application (2025-2030) & (US$ Million)
Table 44. Global Octreotide Revenue Share by Application (2019-2024)
Table 45. Global Octreotide Revenue Share by Application (2025-2030)
Table 46. Octreotide Price by Application (2019-2024) & (USD/Gram)
Table 47. Global Octreotide Price Forecast by Application (2025-2030) & (USD/Gram)
Table 48. US & Canada Octreotide Sales by Type (2019-2024) & (Gram)
Table 49. US & Canada Octreotide Sales by Type (2025-2030) & (Gram)
Table 50. US & Canada Octreotide Revenue by Type (2019-2024) & (US$ Million)
Table 51. US & Canada Octreotide Revenue by Type (2025-2030) & (US$ Million)
Table 52. US & Canada Octreotide Sales by Application (2019-2024) & (Gram)
Table 53. US & Canada Octreotide Sales by Application (2025-2030) & (Gram)
Table 54. US & Canada Octreotide Revenue by Application (2019-2024) & (US$ Million)
Table 55. US & Canada Octreotide Revenue by Application (2025-2030) & (US$ Million)
Table 56. US & Canada Octreotide Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 57. US & Canada Octreotide Revenue by Country (2019-2024) & (US$ Million)
Table 58. US & Canada Octreotide Revenue by Country (2025-2030) & (US$ Million)
Table 59. US & Canada Octreotide Sales by Country (2019-2024) & (Gram)
Table 60. US & Canada Octreotide Sales by Country (2025-2030) & (Gram)
Table 61. Europe Octreotide Sales by Type (2019-2024) & (Gram)
Table 62. Europe Octreotide Sales by Type (2025-2030) & (Gram)
Table 63. Europe Octreotide Revenue by Type (2019-2024) & (US$ Million)
Table 64. Europe Octreotide Revenue by Type (2025-2030) & (US$ Million)
Table 65. Europe Octreotide Sales by Application (2019-2024) & (Gram)
Table 66. Europe Octreotide Sales by Application (2025-2030) & (Gram)
Table 67. Europe Octreotide Revenue by Application (2019-2024) & (US$ Million)
Table 68. Europe Octreotide Revenue by Application (2025-2030) & (US$ Million)
Table 69. Europe Octreotide Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 70. Europe Octreotide Revenue by Country (2019-2024) & (US$ Million)
Table 71. Europe Octreotide Revenue by Country (2025-2030) & (US$ Million)
Table 72. Europe Octreotide Sales by Country (2019-2024) & (Gram)
Table 73. Europe Octreotide Sales by Country (2025-2030) & (Gram)
Table 74. China Octreotide Sales by Type (2019-2024) & (Gram)
Table 75. China Octreotide Sales by Type (2025-2030) & (Gram)
Table 76. China Octreotide Revenue by Type (2019-2024) & (US$ Million)
Table 77. China Octreotide Revenue by Type (2025-2030) & (US$ Million)
Table 78. China Octreotide Sales by Application (2019-2024) & (Gram)
Table 79. China Octreotide Sales by Application (2025-2030) & (Gram)
Table 80. China Octreotide Revenue by Application (2019-2024) & (US$ Million)
Table 81. China Octreotide Revenue by Application (2025-2030) & (US$ Million)
Table 82. Asia Octreotide Sales by Type (2019-2024) & (Gram)
Table 83. Asia Octreotide Sales by Type (2025-2030) & (Gram)
Table 84. Asia Octreotide Revenue by Type (2019-2024) & (US$ Million)
Table 85. Asia Octreotide Revenue by Type (2025-2030) & (US$ Million)
Table 86. Asia Octreotide Sales by Application (2019-2024) & (Gram)
Table 87. Asia Octreotide Sales by Application (2025-2030) & (Gram)
Table 88. Asia Octreotide Revenue by Application (2019-2024) & (US$ Million)
Table 89. Asia Octreotide Revenue by Application (2025-2030) & (US$ Million)
Table 90. Asia Octreotide Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 91. Asia Octreotide Revenue by Region (2019-2024) & (US$ Million)
Table 92. Asia Octreotide Revenue by Region (2025-2030) & (US$ Million)
Table 93. Asia Octreotide Sales by Region (2019-2024) & (Gram)
Table 94. Asia Octreotide Sales by Region (2025-2030) & (Gram)
Table 95. Middle East, Africa and Latin America Octreotide Sales by Type (2019-2024) & (Gram)
Table 96. Middle East, Africa and Latin America Octreotide Sales by Type (2025-2030) & (Gram)
Table 97. Middle East, Africa and Latin America Octreotide Revenue by Type (2019-2024) & (US$ Million)
Table 98. Middle East, Africa and Latin America Octreotide Revenue by Type (2025-2030) & (US$ Million)
Table 99. Middle East, Africa and Latin America Octreotide Sales by Application (2019-2024) & (Gram)
Table 100. Middle East, Africa and Latin America Octreotide Sales by Application (2025-2030) & (Gram)
Table 101. Middle East, Africa and Latin America Octreotide Revenue by Application (2019-2024) & (US$ Million)
Table 102. Middle East, Africa and Latin America Octreotide Revenue by Application (2025-2030) & (US$ Million)
Table 103. Middle East, Africa and Latin America Octreotide Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 104. Middle East, Africa and Latin America Octreotide Revenue by Country (2019-2024) & (US$ Million)
Table 105. Middle East, Africa and Latin America Octreotide Revenue by Country (2025-2030) & (US$ Million)
Table 106. Middle East, Africa and Latin America Octreotide Sales by Country (2019-2024) & (Gram)
Table 107. Middle East, Africa and Latin America Octreotide Sales by Country (2025-2030) & (Gram)
Table 108. Novartis Company Information
Table 109. Novartis Description and Major Businesses
Table 110. Novartis Octreotide Sales (Gram), Revenue (US$ Million), Price (USD/Gram) and Gross Margin (2019-2024)
Table 111. Novartis Octreotide Product Model Numbers, Pictures, Descriptions and Specifications
Table 112. Novartis Recent Developments
Table 113. Sun Pharmaceutical Company Information
Table 114. Sun Pharmaceutical Description and Major Businesses
Table 115. Sun Pharmaceutical Octreotide Sales (Gram), Revenue (US$ Million), Price (USD/Gram) and Gross Margin (2019-2024)
Table 116. Sun Pharmaceutical Octreotide Product Model Numbers, Pictures, Descriptions and Specifications
Table 117. Sun Pharmaceutical Recent Developments
Table 118. Chengdu Tiantaishan pharmaceutical Company Information
Table 119. Chengdu Tiantaishan pharmaceutical Description and Major Businesses
Table 120. Chengdu Tiantaishan pharmaceutical Octreotide Sales (Gram), Revenue (US$ Million), Price (USD/Gram) and Gross Margin (2019-2024)
Table 121. Chengdu Tiantaishan pharmaceutical Octreotide Product Model Numbers, Pictures, Descriptions and Specifications
Table 122. Chengdu Tiantaishan pharmaceutical Recent Developments
Table 123. Sinopharm A-Think Pharmaceuticals Company Information
Table 124. Sinopharm A-Think Pharmaceuticals Description and Major Businesses
Table 125. Sinopharm A-Think Pharmaceuticals Octreotide Sales (Gram), Revenue (US$ Million), Price (USD/Gram) and Gross Margin (2019-2024)
Table 126. Sinopharm A-Think Pharmaceuticals Octreotide Product Model Numbers, Pictures, Descriptions and Specifications
Table 127. Sinopharm A-Think Pharmaceuticals Recent Developments
Table 128. Sihuan Pharmaceutical Holdings Group Company Information
Table 129. Sihuan Pharmaceutical Holdings Group Description and Major Businesses
Table 130. Sihuan Pharmaceutical Holdings Group Octreotide Sales (Gram), Revenue (US$ Million), Price (USD/Gram) and Gross Margin (2019-2024)
Table 131. Sihuan Pharmaceutical Holdings Group Octreotide Product Model Numbers, Pictures, Descriptions and Specifications
Table 132. Sihuan Pharmaceutical Holdings Group Recent Developments
Table 133. Shanghai Soho-Yiming Pharmaceuticals Company Information
Table 134. Shanghai Soho-Yiming Pharmaceuticals Description and Major Businesses
Table 135. Shanghai Soho-Yiming Pharmaceuticals Octreotide Sales (Gram), Revenue (US$ Million), Price (USD/Gram) and Gross Margin (2019-2024)
Table 136. Shanghai Soho-Yiming Pharmaceuticals Octreotide Product Model Numbers, Pictures, Descriptions and Specifications
Table 137. Shanghai Soho-Yiming Pharmaceuticals Recent Developments
Table 138. Yibin Pharmaceutical Company Information
Table 139. Yibin Pharmaceutical Description and Major Businesses
Table 140. Yibin Pharmaceutical Octreotide Sales (Gram), Revenue (US$ Million), Price (USD/Gram) and Gross Margin (2019-2024)
Table 141. Yibin Pharmaceutical Octreotide Product Model Numbers, Pictures, Descriptions and Specifications
Table 142. Yibin Pharmaceutical Recent Developments
Table 143. Key Raw Materials Lists
Table 144. Raw Materials Key Suppliers Lists
Table 145. Octreotide Distributors List
Table 146. Octreotide Customers List
Table 147. Octreotide Market Trends
Table 148. Octreotide Market Drivers
Table 149. Octreotide Market Challenges
Table 150. Octreotide Market Restraints
Table 151. Research Programs/Design for This Report
Table 152. Key Data Information from Secondary Sources
Table 153. Key Data Information from Primary Sources
List of Figures
Figure 1. Octreotide Product Picture
Figure 2. Global Octreotide Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Octreotide Market Share by Type in 2023 & 2030
Figure 4. Octreotide Injection Product Picture
Figure 5. Octreotide Powder Product Picture
Figure 6. Octreotide Microspheres Product Picture
Figure 7. Global Octreotide Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
Figure 8. Global Octreotide Market Share by Application in 2023 & 2030
Figure 9. Treating Severe Diarrhea
Figure 10. Treating Acromegaly
Figure 11. Others
Figure 12. Octreotide Report Years Considered
Figure 13. Global Octreotide Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 14. Global Octreotide Revenue 2019-2030 (US$ Million)
Figure 15. Global Octreotide Revenue Market Share by Region in Percentage: 2023 Versus 2030
Figure 16. Global Octreotide Revenue Market Share by Region (2019-2030)
Figure 17. Global Octreotide Sales 2019-2030 ((Gram)
Figure 18. Global Octreotide Sales Market Share by Region (2019-2030)
Figure 19. US & Canada Octreotide Sales YoY (2019-2030) & (Gram)
Figure 20. US & Canada Octreotide Revenue YoY (2019-2030) & (US$ Million)
Figure 21. Europe Octreotide Sales YoY (2019-2030) & (Gram)
Figure 22. Europe Octreotide Revenue YoY (2019-2030) & (US$ Million)
Figure 23. China Octreotide Sales YoY (2019-2030) & (Gram)
Figure 24. China Octreotide Revenue YoY (2019-2030) & (US$ Million)
Figure 25. Asia (excluding China) Octreotide Sales YoY (2019-2030) & (Gram)
Figure 26. Asia (excluding China) Octreotide Revenue YoY (2019-2030) & (US$ Million)
Figure 27. Middle East, Africa and Latin America Octreotide Sales YoY (2019-2030) & (Gram)
Figure 28. Middle East, Africa and Latin America Octreotide Revenue YoY (2019-2030) & (US$ Million)
Figure 29. The Octreotide Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2023
Figure 30. The Top 5 and 10 Largest Manufacturers of Octreotide in the World: Market Share by Octreotide Revenue in 2023
Figure 31. Global Octreotide Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 32. Global Octreotide Sales Market Share by Type (2019-2030)
Figure 33. Global Octreotide Revenue Market Share by Type (2019-2030)
Figure 34. Global Octreotide Sales Market Share by Application (2019-2030)
Figure 35. Global Octreotide Revenue Market Share by Application (2019-2030)
Figure 36. US & Canada Octreotide Sales Market Share by Type (2019-2030)
Figure 37. US & Canada Octreotide Revenue Market Share by Type (2019-2030)
Figure 38. US & Canada Octreotide Sales Market Share by Application (2019-2030)
Figure 39. US & Canada Octreotide Revenue Market Share by Application (2019-2030)
Figure 40. US & Canada Octreotide Revenue Share by Country (2019-2030)
Figure 41. US & Canada Octreotide Sales Share by Country (2019-2030)
Figure 42. U.S. Octreotide Revenue (2019-2030) & (US$ Million)
Figure 43. Canada Octreotide Revenue (2019-2030) & (US$ Million)
Figure 44. Europe Octreotide Sales Market Share by Type (2019-2030)
Figure 45. Europe Octreotide Revenue Market Share by Type (2019-2030)
Figure 46. Europe Octreotide Sales Market Share by Application (2019-2030)
Figure 47. Europe Octreotide Revenue Market Share by Application (2019-2030)
Figure 48. Europe Octreotide Revenue Share by Country (2019-2030)
Figure 49. Europe Octreotide Sales Share by Country (2019-2030)
Figure 50. Germany Octreotide Revenue (2019-2030) & (US$ Million)
Figure 51. France Octreotide Revenue (2019-2030) & (US$ Million)
Figure 52. U.K. Octreotide Revenue (2019-2030) & (US$ Million)
Figure 53. Italy Octreotide Revenue (2019-2030) & (US$ Million)
Figure 54. Russia Octreotide Revenue (2019-2030) & (US$ Million)
Figure 55. China Octreotide Sales Market Share by Type (2019-2030)
Figure 56. China Octreotide Revenue Market Share by Type (2019-2030)
Figure 57. China Octreotide Sales Market Share by Application (2019-2030)
Figure 58. China Octreotide Revenue Market Share by Application (2019-2030)
Figure 59. Asia Octreotide Sales Market Share by Type (2019-2030)
Figure 60. Asia Octreotide Revenue Market Share by Type (2019-2030)
Figure 61. Asia Octreotide Sales Market Share by Application (2019-2030)
Figure 62. Asia Octreotide Revenue Market Share by Application (2019-2030)
Figure 63. Asia Octreotide Revenue Share by Region (2019-2030)
Figure 64. Asia Octreotide Sales Share by Region (2019-2030)
Figure 65. Japan Octreotide Revenue (2019-2030) & (US$ Million)
Figure 66. South Korea Octreotide Revenue (2019-2030) & (US$ Million)
Figure 67. China Taiwan Octreotide Revenue (2019-2030) & (US$ Million)
Figure 68. Southeast Asia Octreotide Revenue (2019-2030) & (US$ Million)
Figure 69. India Octreotide Revenue (2019-2030) & (US$ Million)
Figure 70. Middle East, Africa and Latin America Octreotide Sales Market Share by Type (2019-2030)
Figure 71. Middle East, Africa and Latin America Octreotide Revenue Market Share by Type (2019-2030)
Figure 72. Middle East, Africa and Latin America Octreotide Sales Market Share by Application (2019-2030)
Figure 73. Middle East, Africa and Latin America Octreotide Revenue Market Share by Application (2019-2030)
Figure 74. Middle East, Africa and Latin America Octreotide Revenue Share by Country (2019-2030)
Figure 75. Middle East, Africa and Latin America Octreotide Sales Share by Country (2019-2030)
Figure 76. Brazil Octreotide Revenue (2019-2030) & (US$ Million)
Figure 77. Mexico Octreotide Revenue (2019-2030) & (US$ Million)
Figure 78. Turkey Octreotide Revenue (2019-2030) & (US$ Million)
Figure 79. Israel Octreotide Revenue (2019-2030) & (US$ Million)
Figure 80. GCC Countries Octreotide Revenue (2019-2030) & (US$ Million)
Figure 81. Octreotide Value Chain
Figure 82. Octreotide Production Process
Figure 83. Channels of Distribution
Figure 84. Distributors Profiles
Figure 85. Bottom-up and Top-down Approaches for This Report
Figure 86. Data Triangulation
Figure 87. Key Executives Interviewed
KEY QUESTIONS ADDRESSED BY THE REPORT
What was the global market size of Octreotide in 2030?
The global market size of Octreotide in 2030 was 2 Million USD.
What is the annual compound growth rate of the global Octreotide market size from 2024 to 2030?
Which region is expected to have the highest market share?
Which companies rank high in the global Octreotide market?
What was the global market size of Octreotide in 2024?
Related Reports
Global Octreotide Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Octreotide market size was US$ 2.77 million in 2025 and is forecast to reach a readjusted size of US$ 2.27 million by 2032 with a CAGR of -2.8% during the forecast period 2026-2032.
Published Date: 2026-01-04
Pages: 78
USD 4250.00
(Single User License)
Global Octreotide Market Research Report 2026
The global Octreotide market was valued at US$ 2.77 million in 2025 and is anticipated to reach US$ 2.27 million by 2032, at a CAGR of -2.8% from 2026 to 2032.
Published Date: 2026-01-04
Pages: 109
USD 2900.00
(Single User License)
Octreotide- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Octreotide was estimated to be worth US$ 2.77 million in 2025 and is projected to reach US$ 2.27 million, growing at a CAGR of -2.8% from 2026 to 2032.
Published Date: 2026-01-04
Pages: 107
USD 3950.00
(Single User License)
Global Octreotide Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Octreotide market is projected to grow from US$ 2.8 million in 2024 to US$ 2.3 million by 2031, at a CAGR of -2.8% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-09-11
Pages: 132
USD 4900.00
(Single User License)
Global Octreotide Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031
In 2024, the global market size of Octreotide was estimated to be worth US$ 2.8 million and is forecast to reach approximately US$ 2.3 million by 2031 with a CAGR of -2.8% during the forecast period 2025-2031.
Published Date: 2025-03-28
Pages: 137
USD 5900.00
(Single User License)
Global Octreotide Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Octreotide market size was US$ 2.8 million in 2024 and is forecast to a readjusted size of US$ 2.3 million by 2031 with a CAGR of -2.8% during the forecast period 2025-2031.
Published Date: 2025-03-19
Pages: 80
USD 4250.00
(Single User License)
Octreotide- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Octreotide was estimated to be worth US$ 2.8 million in 2024 and is forecast to a readjusted size of US$ 2.3 million by 2031 with a CAGR of -2.8% during the forecast period 2025-2031.
Published Date: 2025-01-16
Pages: 103
USD 3950.00
(Single User License)
Global Octreotide Market Research Report 2025
The global market for Octreotide was valued at US$ 2.8 million in the year 2024 and is projected to reach a revised size of US$ 2.3 million by 2031, growing at a CAGR of -2.8% during the forecast period.
Published Date: 2025-01-16
Pages: 78
USD 2900.00
(Single User License)
Global Octreotide Industry Research Report, Growth Trends and Competitive Analysis 2024-2030
Octreotide is an octapeptide that mimics natural somatostatin pharmacologically，it is a more potent inhibitor of growth hormone, glucagon, and insulin than the natural hormone. Usually in the form of a salt of acetic acid.
Published Date: 2024-04-17
Pages: 141
USD 5600.00
(Single User License)
Global Octreotide Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2024-2030
Octreotide is an octapeptide that mimics natural somatostatin pharmacologically，it is a more potent inhibitor of growth hormone, glucagon, and insulin than the natural hormone. Usually in the form of a salt of acetic acid.
Published Date: 2024-04-16
Pages: 126
USD 5900.00
(Single User License)
Global Octreotide Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Octreotide market size was US$ 2.77 million in 2025 and is forecast to reach a readjusted size of US$ 2.27 million by 2032 with a CAGR of -2.8% during the forecast period 2026-2032.
Published: 2026-01-04
Pages: 78
USD 4250.00 (Single User License)Global Octreotide Market Research Report 2026
The global Octreotide market was valued at US$ 2.77 million in 2025 and is anticipated to reach US$ 2.27 million by 2032, at a CAGR of -2.8% from 2026 to 2032.
Published: 2026-01-04
Pages: 109
USD 2900.00 (Single User License)Octreotide- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Octreotide was estimated to be worth US$ 2.77 million in 2025 and is projected to reach US$ 2.27 million, growing at a CAGR of -2.8% from 2026 to 2032.
Published: 2026-01-04
Pages: 107
USD 3950.00 (Single User License)Global Octreotide Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Octreotide market is projected to grow from US$ 2.8 million in 2024 to US$ 2.3 million by 2031, at a CAGR of -2.8% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-09-11
Pages: 132
USD 4900.00 (Single User License)Global Octreotide Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031
In 2024, the global market size of Octreotide was estimated to be worth US$ 2.8 million and is forecast to reach approximately US$ 2.3 million by 2031 with a CAGR of -2.8% during the forecast period 2025-2031.
Published: 2025-03-28
Pages: 137
USD 5900.00 (Single User License)Global Octreotide Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Octreotide market size was US$ 2.8 million in 2024 and is forecast to a readjusted size of US$ 2.3 million by 2031 with a CAGR of -2.8% during the forecast period 2025-2031.
Published: 2025-03-19
Pages: 80
USD 4250.00 (Single User License)Octreotide- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Octreotide was estimated to be worth US$ 2.8 million in 2024 and is forecast to a readjusted size of US$ 2.3 million by 2031 with a CAGR of -2.8% during the forecast period 2025-2031.
Published: 2025-01-16
Pages: 103
USD 3950.00 (Single User License)Global Octreotide Market Research Report 2025
The global market for Octreotide was valued at US$ 2.8 million in the year 2024 and is projected to reach a revised size of US$ 2.3 million by 2031, growing at a CAGR of -2.8% during the forecast period.
Published: 2025-01-16
Pages: 78
USD 2900.00 (Single User License)Global Octreotide Industry Research Report, Growth Trends and Competitive Analysis 2024-2030
Octreotide is an octapeptide that mimics natural somatostatin pharmacologically，it is a more potent inhibitor of growth hormone, glucagon, and insulin than the natural hormone. Usually in the form of a salt of acetic acid.
Published: 2024-04-17
Pages: 141
USD 5600.00 (Single User License)Global Octreotide Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2024-2030
Octreotide is an octapeptide that mimics natural somatostatin pharmacologically，it is a more potent inhibitor of growth hormone, glucagon, and insulin than the natural hormone. Usually in the form of a salt of acetic acid.
Published: 2024-04-16
Pages: 126
USD 5900.00 (Single User License)
CHOOSE LICENSE TYPE
USD 4900.00
USD 7350.00
USD 9800.00
Add to Cart
Buy Now
HAVE A QUESTION?
General Email:
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now